Overview

A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).

Status:
Completed

Trial end date:
2003-01-01

Target enrollment:

Participant gender:

Summary

The objective of the trial is to investigate the analgesic efficacy of SPM 927 in subjects with moderate to severe neuropathic pain due to Postherpetic Neuralgia (PHN)

Phase:

Phase 2

Details

Lead Sponsor:

UCB Pharma

Treatments:

Lacosamide